ArticleNPJ science of food2026
Tailored effects of coarse grain substitution on blood pressure via gut microbiota-metabolite networks and host gene variants: a randomized controlled trial.
Article in NPJ science of food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
We previously reported inverse associations of coarse grain (CG) intake with blood pressure, mediated by metabolites and gut microbiota. In this 12-week randomized controlled trial among 172 prehypertension participants, both the CG (100 g/day) group and the control group (refined grain) showed significant reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) over 12 weeks, with no significant time by group interaction. In the exploratory analyses of secondary outcomes, significant time by group interactions were detected for 26 taxa (such as g__Lactococcus and g__Faecalibacterium), associated with 23 differential fecal metabolites, which in turn were correlated with blood pressure changes over the CG intervention. Microbial ATP-binding cassette transporter was highlighted in the pathway annotation for the CG-derived differential microbial taxa. Baseline gut microbiota exhibited predictive potential for blood pressure reduction, while host ABO variance rs514659 modulated the intervention effect on SBP and DBP (P interaction < 0.05), providing preliminary evidence for the tailored nutrition strategies optimizing blood pressure and gut microbiota profiles.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.